Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
On Campus Blog
Tim Post

U of M gets $350,000 from drug companies in 2010

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

The University of Minnesota and the Mayo Clinic received $650,000 from drug companies in 2010.

That's from reporter Christopher Snowbeck, who analyzed annual reports to the Minnesota Board of Pharmacy for a story in today's Pioneer Press.

Snowbeck reports that $350,000 in drug company money went to the U in 2010.  The money is used to fund research and fellowship programs.

The U of M is working to foster closer relationships with business and industry, so don't be surprised if it's a source of funding that grows in coming years.

Drug company relationships with the U and its doctors was the focus of a revamped conflict of interest policy that went into place at the U just last year.

And last week the U of M sent a note caution to one of its surgeons, Dr. David Polly, noting he had violated conflict of interest closure requirements.  Polly failed to mention payments he received from Fridley-based medical device manufacturer Medtronic in two published journal articles and on one research poster.